{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T02:03:02Z","timestamp":1775872982495,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction and Hypothesis<\/jats:title>\n            <jats:p>The objective of this study was to evaluate whether preoperative administration of tamsulosin would decrease the frequency of postoperative urinary retention (POUR) after mid-urethral sling (MUS) placement<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was a prospective randomized, double-blinded, placebo-controlled trial of patients with SUI who underwent elective MUS placement at a single institution. Patients scheduled to undergo MUS placement consented, were enrolled, and were randomized to receive either a single tablet of tamsulosin 0.4 mg or placebo in the preoperative holding area on the day of their surgery. We then evaluated the rate of POUR after administration of tamsulosin compared with placebo using appropriate statistical methods. Sample size was calculated to include 160 patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 161 patients (81 placebo, 80 tamsulosin) were analyzed. The incidence of POUR was similar between the tamsulosin and placebo groups (17.7% vs 19.8%, <jats:italic>p<\/jats:italic> = 0.7420). Secondary outcomes, including unplanned admissions, urinary-tract infections (UTIs), and hypotension, did not differ significantly between groups. A subgroup analysis of patients undergoing MUS without concomitant prolapse surgery suggested a trend toward lower POUR rates in the tamsulosin group (7.5% vs 16.7%, <jats:italic>p<\/jats:italic> = 0.142), although this was not statistically significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These results suggest that single-dose preoperative tamsulosin might not have an effect on postoperative urinary retention after MUS placement, with or without concomitant reconstructive pelvic surgery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00192-025-06120-2","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T09:28:24Z","timestamp":1744450104000},"page":"1085-1093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Preoperative Tamsulosin on Postoperative Urinary Retention Prevention After Sling Placement: A Randomized Controlled Trial"],"prefix":"10.1007","volume":"36","author":[{"given":"Angela","family":"Leffelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Chill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Paya-Ten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Hadizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazaleh","family":"Rostaminia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"4","key":"6120_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/SPV.0000000000001344","volume":"29","author":"CD McDermott","year":"2023","unstructured":"McDermott CD, Tunitsky-Bitton E, Due\u00f1as-Garcia OF, Willis-Gray MG, Cadish LA, Edenfield A, Wang R, Meriwether K, Mueller ER. Postoperative urinary retention. Urogynecology. 2023;29(4):381\u201396.","journal-title":"Urogynecology"},{"key":"6120_CR2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00192-016-2975-y","volume":"27","author":"R Wang","year":"2016","unstructured":"Wang R, Won S, Haviland MJ, Von Bargen E, Hacker MR, Li J, Lefevre R. Voiding trial outcome following pelvic floor repair without incontinence procedures. Int Urogynecol J. 2016;27:1215\u201320.","journal-title":"Int Urogynecol J"},{"issue":"3","key":"6120_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/AOG.0b013e318229e8dd","volume":"118","author":"EJ Geller","year":"2011","unstructured":"Geller EJ, Hankins KJ, Parnell BA, Robinson BL, Dunivan GC. Diagnostic accuracy of retrograde and spontaneous voiding trials for postoperative voiding dysfunction: a randomized controlled trial. Obstet Gynecol. 2011;118(3):637\u201342.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6120_CR4","first-page":"e256","volume":"27","author":"MG Willis-Gray","year":"2021","unstructured":"Willis-Gray MG, Wu JM, Field C, Pulliam S, Husk KE, Brueseke TJ, Geller EJ, Connolly A, Dieter AA. Is a postvoid residual necessary? A randomized trial of two postoperative voiding protocols. Urogynecology. 2021;27(2):e256\u201360.","journal-title":"Urogynecology"},{"key":"6120_CR5","volume-title":"Post-op urinary retention","author":"A Pomajzl","year":"2019","unstructured":"Pomajzl A, Siref LE. Post-op urinary retention. Treasure Island: StatPearls; 2019."},{"key":"6120_CR6","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s11255-012-0275-0","volume":"44","author":"LE Meyer","year":"2012","unstructured":"Meyer LE, Brown JN. Tamsulosin for voiding dysfunction in women. Int Urol Nephrol. 2012;44:1649\u201356.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"6120_CR7","doi-asserted-by":"publisher","first-page":"274.e1","DOI":"10.1016\/j.ajog.2021.04.236","volume":"225","author":"GC Chapman","year":"2021","unstructured":"Chapman GC, Sheyn D, Slopnick EA, Roberts K, El-Nashar SA, Henderson JW, Mangel J, Hijaz AK, Pollard RR, Mahajan ST. Tamsulosin vs placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery: a multicenter randomized controlled trial. Am J Obstet Gynecol. 2021;225(3):274.e1\u201311.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"6120_CR8","first-page":"682","volume":"26","author":"GC Chapman","year":"2020","unstructured":"Chapman GC, Sheyn D, Petrikovets A, Mahajan ST, El-Nashar S, Pollard R, Mangel JM. Tamsulosin to prevent postoperative urinary retention after female pelvic reconstructive surgery. Urogynecology. 2020;26(11):682\u20137.","journal-title":"Urogynecology"},{"issue":"4","key":"6120_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/00016348309156234","volume":"62","author":"PM Livne","year":"1983","unstructured":"Livne PM, Kaplan B, Ovadia Y, Servadio C. Prevention of post-hysterectomy urinary retention by alpha-adrenergic blocker. Acta Obstet Gynecol Scand. 1983;62(4):337\u201340.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"6120_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1590\/S1677-5538.IBJU.2014.01.05","volume":"40","author":"AH Madani","year":"2014","unstructured":"Madani AH, Aval HB, Mokhtari G, Nasseh H, Esmaeili S, Shakiba M, Damavand RS, Saadat SMS. Effectiveness of tamsulosin in prevention of post-operative urinary retention: a randomized double-blind placebo-controlled study. Int Braz J Urol. 2014;40(1):30\u20136.","journal-title":"Int Braz J Urol"},{"issue":"6","key":"6120_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4111\/kju.2012.53.6.419","volume":"53","author":"M Mohammadi-Fallah","year":"2012","unstructured":"Mohammadi-Fallah M, Hamedanchi S, Tayyebi-Azar A. Preventive effect of tamsulosin on postoperative urinary retention. Korean J Urol. 2012;53(6):419\u201323.","journal-title":"Korean J Urol"},{"issue":"6","key":"6120_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0090-4295(01)01346-2","volume":"58","author":"MP O\u2019Leary","year":"2001","unstructured":"O\u2019Leary MP. Tamsulosin: current clinical experience. Urology. 2001;58(6):42\u20138.","journal-title":"Urology"},{"key":"6120_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2165\/00002512-200219020-00004","volume":"19","author":"CJ Dunn","year":"2002","unstructured":"Dunn CJ, Matheson A, Faulds DM. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging. 2002;19:135\u201361.","journal-title":"Drugs Aging"},{"key":"6120_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1464-410X.2006.06494.x","volume":"98","author":"CR Chapple","year":"2006","unstructured":"Chapple CR, Chartier-Kastler E. Pharmacokinetic profile of tamsulosin OCAS. BJU Int. 2006;98:9\u201312.","journal-title":"BJU Int"},{"issue":"6","key":"6120_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jmig.2024.04.003","volume":"31","author":"A Leffelman","year":"2024","unstructured":"Leffelman A, Chill HH, Kar A, Gilani S, Chang C, Goldberg RP, Rostaminia G. Assessment of urinary dysfunction after midurethral sling placement: a comparison of two voiding trial methods. J Minim Invasive Gynecol. 2024;31(6):533\u201340.","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"6120_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12905-021-01330-4","volume":"21","author":"BC Anglim","year":"2021","unstructured":"Anglim BC, Ramage K, Sandwith E, Brennand EA, Brennand EA; Calgary Women\u2019s Pelvic Health Research Group. Postoperative urinary retention after pelvic organ prolapse surgery: influence of peri-operative factors and trial of void protocol. BMC Womens Health. 2021;21(1):195.","journal-title":"BMC Womens Health"},{"issue":"4","key":"6120_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.juro.2010.05.096","volume":"184","author":"JQ Pulvino","year":"2010","unstructured":"Pulvino JQ, Duecy EE, Buchsbaum GM, Flynn MK. Comparison of 2 techniques to predict voiding efficiency after inpatient urogynecologic surgery. J Urol. 2010;184(4):1408\u201312.","journal-title":"J Urol"},{"issue":"2","key":"6120_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5152\/jtgga.2012.14","volume":"13","author":"H Celik","year":"2012","unstructured":"Celik H, Harmanl\u0131 O. Evaluation and management of voiding dysfunction after midurethral sling procedures. J Turk Ger Gynecol Assoc. 2012;13(2):123\u20137.","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"6","key":"6120_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4111\/kju.2014.55.6.400","volume":"55","author":"SW Kim","year":"2014","unstructured":"Kim SW, Kim WH, Yoon BI, Cho Y-H, Sohn DW. The changes of voiding pattern after midurethral sling between pure stress urinary incontinence and stress urinary incontinence with overactive bladder group. Korean J Urol. 2014;55(6):400\u20134.","journal-title":"Korean J Urol"},{"issue":"5 Suppl 2","key":"6120_CR20","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.5489\/cuaj.1462","volume":"6","author":"VW Nitti","year":"2012","unstructured":"Nitti VW. Complications of midurethral slings and their management. Can Urol Assoc J. 2012;6(5 Suppl 2):S120\u20132.","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"6120_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/SPV.0000000000001632","volume":"31","author":"J Song","year":"2025","unstructured":"Song J, Carrillo L, Tibon J, Botros-Brey S, Evans E, Alas A. Tamsulosin to prevent urinary retention after vaginal urogynecologic surgery. Urogynecology 2025;31(4):397\u2013404. https:\/\/doi.org\/10.1097\/SPV.0000000000001632.","journal-title":"Urogynecology"},{"issue":"6","key":"6120_CR22","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0002-9378(03)00932-3","volume":"189","author":"EA Elkadry","year":"2003","unstructured":"Elkadry EA, Kenton KS, FitzGerald MP, Shott S, Brubaker L. Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol. 2003;189(6):1551\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6120_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/AOG.0000000000001472","volume":"128","author":"K Propst","year":"2016","unstructured":"Propst K, Tunitsky-Bitton E, O\u2019Sullivan DM, Steinberg AC, LaSala C. Phenazopyridine for evaluation of ureteral patency: a randomized controlled trial. Obstet Gynecol. 2016;128(2):348\u201355.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"6120_CR24","first-page":"CD013313","volume":"2019","author":"D Eliezer","year":"2019","unstructured":"Eliezer D, Deshpande AV, Starkey MR, Samnakay N, Oldmeadow C, Kernohan A. Alpha blockers for treating functional daytime urinary incontinence in children. Cochrane Database Syst Rev. 2019;2019(4):CD013313.","journal-title":"Cochrane Database Syst Rev"},{"key":"6120_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2165\/00003495-199652060-00012","volume":"52","author":"MI Wilde","year":"1996","unstructured":"Wilde MI, McTavish D. Tamsulosin: a review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia. Drugs. 1996;52:883\u201398.","journal-title":"Drugs"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06120-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T13:18:42Z","timestamp":1750511922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06120-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6120"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06120-2","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study underwent full-board review, was approved by the NorthShore University Health Systems Board committee (IRB# EH22 -\u2009470), and was registered with clinicaltrials.gov (ID# NCT05753670) prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}